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ABSTRACT The human immunodeﬁciency virus type 1 (HIV-1) fusion peptide serves as a useful model system for
understanding viral/target cell fusion, at least to the lipid mixing stage. Previous solid-state NMR studies have shown that the
peptide adopts an oligomeric b-strand structure when associated with a lipid and cholesterol mixture close to that of membranes
of host cells of the virus. In this study, this structure was further investigated using four different peptide constructs. In aqueous
buffer solution, two of the constructs were primarily monomeric whereas the other two constructs had signiﬁcant populations of
oligomers/aggregates. NMR measurements for all membrane-associated peptide constructs were consistent with oligomeric
b-strand structure. Thus, constructs that are monomeric in solution can be converted to oligomers as a result of membrane
association. In addition, samples prepared by very different methods had very similar NMR spectra, which indicates that the
b-strand structure is an equilibrium rather than a kinetically trapped structure. Lipid mixing assays were performed to assess the
fusogenicities of the different constructs, and there was not a linear correlation between the solution oligomeric state and
fusogenicity. However, the functional assays do suggest that small oligomers may be more fusogenic than either monomers or
large aggregates.
INTRODUCTION
Fusion between the membranes of enveloped viruses such as
human immunodeﬁciency virus type 1 (HIV-1) and inﬂuenza
and themembranes of their target host cells is an essential step
in infection (Hernandez et al., 1996; Dimitrov, 2000; Eckert
andKim, 2001; Blumenthal et al., 2003). For the HIV-1 virus,
this process is mediated by the integral membrane viral
envelope gp41 protein that contains an N-terminal ;20-
residue apolar fusion peptide (FP) domain. This domain is
believed to interact with the target cell membrane and to
catalyze membrane fusion. The free fusion peptide has also
been shown to be a useful model to understand fusion, at least
to the lipid mixing stage. For example, the free HIV-1 peptide
causes fusion of liposomes and erythrocytes, and numerous
mutational studies have shown strong correlations between
fusion peptide-induced liposome fusion and viral/host cell
fusion (Freed et al., 1990, 1992; Rafalski et al., 1990;
Slepushkin et al., 1990;Martin et al., 1993, 1996; Nieva et al.,
1994, 1998; Mobley et al., 1995; Schaal et al., 1995;
Delahunty et al., 1996; Durell et al., 1997; Kliger et al.,
1997; Pereira et al., 1997; Pecheur et al., 1999; Pritsker et al.,
1999). Recent studies suggest that envelope protein regions
other than the fusion peptide also interact with membranes
and play a role in fusion (Epand et al., 1999; Peisajovich et al.,
2000a,b, 2003; Suarez et al., 2000; Sackett and Shai, 2002).
A variety of experimental methods have shown that the
HIV-1 fusion peptide can assume helical or nonhelical
structures in its membrane-associated forms (Rafalski et al.,
1990; Gordon et al., 1992, 2002; Martin et al., 1993, 1996;
Nieva et al., 1994, 1998; Pereira et al., 1995, 1997;
Chang et al., 1997a; Durell et al., 1997; Mobley et al.,
1999; Curtain et al., 1999; Yang et al., 2001a, 2002, 2003;
Bodner et al., 2004). Models for the helical structure have
been developed based on NMR, electron spin resonance
(ESR), infrared, and circular dichroism (CD) data, as well as
computer simulations (Martin et al., 1993, 1996; Chang et al.,
1997a,b, 1999; Chang and Cheng, 1998; Kamath and Wong,
2002; Maddox and Longo, 2002; Wong, 2003).
Fluorescence, ESR, and solid-state NMR data also suggest
that nonhelical HIV-1 fusion peptides form oligomeric
b-strand structures (Gordon et al., 1992; Kliger et al., 1997;
Pritsker et al., 1999; Yang and Weliky, 2003). In particular,
solid-stateNMR rotational-echo double-resonance (REDOR)
experiments were performed on membrane-associated pep-
tide samples in which half of the peptides contained speciﬁc
13C carbonyl backbone labels and the other half of the
peptides contained speciﬁc 15N backbone labels (Yang and
Weliky, 2003). Strong evidence for oligomeric b-strand
structure was provided by observation of a signiﬁcant
reduction of the 13C signals by the 15N nuclei. Analysis of
data from samples that differed in the residue positions of the
labelswas consistentwith approximately equal populations of
parallel and antiparallel strand arrangements.
The possible signiﬁcance of fusion peptide oligomerization
is suggested by atomic-resolution structures of the soluble
ectodomain of gp41 that show stable gp41 trimers (Chan et al.,
1997; Tan et al., 1997;Weissenhorn et al., 1997; Caffrey et al.,
1998; Yang et al., 1999). These structures end ;10 residues
C-terminal of the fusion peptide domain, and their three
N-termini are close together at the ends of an in-register
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helical coiled coil. Thus, it appears that at least three fusion
peptides are in close proximity when they interact with the
target membrane. In the HIV-1 fusion peptide model system,
the biologically relevant topology has been mimicked with
C-terminal cross-linking, and it has been observed that the
cross-linked peptides can induce both a greater ﬁnal extent
and a more rapid rate of fusion than their noncross-linked
analogs (Yang et al., 2003). Similar fusogenic enhancements
have also been observed for inﬂuenza protein domains in
which the fusion peptide was thought to assume the
biologically relevant oligomeric topology (Kim et al., 1996,
1998; Macosko et al., 1997; Epand et al., 1999, 2001; LeDuc
et al., 2000; Leikina et al., 2001). Experiments and modeling
studies further suggest that the fusion site contains multiple
envelope protein trimers and a corresponding high fusion
peptide concentration (Blumenthal et al., 1996; Weissenhorn
et al., 1997; Caffrey et al., 1998; Munoz-Barroso et al., 1998;
Kuhmann et al., 2000; Bentz, 2000a,b; Mittal and Bentz,
2001; Kliger et al., 2001; Lin et al., 2003). In addition, the
functionally disruptive Val-2 to Glu-2 mutation in the gp41
fusion peptide is trans-dominant, i.e., cells expressing 10%
mutant protein and 90%wild-type protein exhibit only 40%of
the fusion activity of cells with 100%wild-type protein (Freed
et al., 1992). One interpretation of these data is that themutant
peptide disrupts the correct assembly of a functionally
important fusion peptide oligomer (Kliger et al., 1997;
Pritsker et al., 1999).
This article investigates the aqueous oligomerization states
of different constructs of model fusion peptides and the
relationships between soluble peptide oligomerization, fusion
activity, and membrane-associated peptide structure. Soluble
peptide oligomerization is considered within the context of
previous studies from our and other research groups. Al-
though we use the term oligomerization, in most studies
the actual numbers of peptides in a soluble cluster or ag-
gregate have not been well deﬁned. In our group, it was
shown that the association state of a 23-residue HIV-1 fusion
peptide depends on the buffer type, pH, and salt concentration
(Yang et al., 2001a). NMR has also been done on FP in
unbuffered aqueous solution at pH 3 and would only be
possible if the peptide were monomeric or formed small
oligomers (Chang et al., 1997b). By contrast, in buffered
neutral pH solutions with 100–150 mMNaCl, FP and related
peptides have been shown to form ﬁlamentous aggregates
(Slepushkin et al., 1992; Pereira et al., 1997). Peptide
oligomerization has also been investigated for a construct
representing residues 5–55 of gp41 (Chang et al., 1999). In
this study, pulsed ﬁeld gradient NMR and light scattering
methodswere applied to the peptide inwater, and gel ﬁltration
chromatography was applied to the peptide in a solution
containing 78% H2O/22% acetonitrile/0.1% triﬂuoracetic
acid (TFA). The derived molecular weights were consistent
with dimeric or trimeric peptide.
In related studies by the Tamm group on the inﬂuenza
fusion peptide, oligomerization of the peptide in aqueous
buffered solution was probed by CD and ESR measurements
(Han and Tamm, 2000a,b). At lower ionic strengths, the CD
spectra were not consistent with either helical or b-strand
structure, and the ESR spectra of spin-labeled peptides
yielded sharp lines, whereas at higher ionic strengths, the CD
spectra were consistent with a mixture of helical and
b-structures, and the ESR spectra were attenuated. The low
and high ionic strength data were interpreted in terms of
monomeric and oligomeric/aggregated peptide states, respec-
tively. In addition, binding of the peptide to membranes was
measured using 50-nM peptide concentrations and variable
concentrations of liposomes composed of 4:1 choline/glycerol
lipids. In low ionic strength buffer at pH 5, thermodynamic
analysis of the data was consistent with an;1-kcal/mol free
energy of peptide self-association in membranes.
Although CD, ESR, light scattering, gel ﬁltration, and
NMR can provide information about oligomerization,
analytical ultracentrifugation is probably the most deﬁnitive
probe of peptide oligomerization in aqueous environments
and is the method of choice for our studies on the HIV-1
fusion peptide. One speciﬁc example of the insight provided
by analytical ultracentrifugation is studies on the previously
described inﬂuenza fusion peptide. We examined two
different inﬂuenza fusion peptide constructs that both
contained C-terminal lysines to improve peptide solubility.
In low ionic strength buffer, a construct with three lysines was
highly aggregated whereas a construct with six lysines was
predominantly monomeric (P. D. Parkanzky, M. Prorok, F. J.
Castellino, and D. P.Weliky, unpublished). For reference, the
construct in theTammstudies contained four lysines (Han and
Tamm, 2000a,b).
In this article, analytical ultracentrifugation characteriza-
tion of the soluble oligomerization state of the peptide is also
related to functional lipid mixing assays and to solid-state
NMR structural studies of membrane-associated fusion
peptides. The NMR samples are typically prepared by mix-
ing aqueous solutions of peptide and liposomes, and the
conditions are intentionally similar to those used in functional
assays so that it is straightforward to correlate structure with
function. Previous NMR data have shown that the fusion
peptide has an oligomeric b-strand structure when associated
with membranes whose lipid headgroup and cholesterol
composition is comparable to that of host cells of the virus
(Yang et al., 2001a,b, 2002, 2003; Yang and Weliky, 2003;
Bodner et al., 2004). However, it was not clear whether
oligomer formation was the result of peptide association with
themembrane orwhether the oligomers preexisted in aqueous
solution and then bound to the membrane. Studies of peptide
aqueous oligomerization can address this question.
It is also noted that the numbers of peptides in the
membrane-associated HIV-1 fusion peptide clusters have not
yet been well deﬁned by experiment. There is qualitative
evidence from solid-state NMR studies that the clusters are
small; in particular, the 13C linewidths are narrower at room
temperature than at50C, and the signal/noise ratio per 13C
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at room temperature is ;1/3 of the value obtained at 50C
(Bodner et al., 2004). Both of these observations suggest that
there is signiﬁcantly greater motion at room temperature than
at 50C, which might be expected for a membrane-
associated cluster with a small number of peptides, but which
would be less likely for a large solid-like peptide aggregate. In
addition, oligomer sizes have been probed in sodium do-
decylsulfate (SDS) gels and show masses up to peptide tet-
ramers (Kliger et al., 1997; Pritsker et al., 1999).
In addition to the investigation of HIV-1 fusion peptide
oligomerization and its relationship to fusogenicity and
membrane-associated structure, this article also considers
the separate question of whether the oligomeric b-strand
structure observed in solid-state NMR studies represents
a thermodynamic equilibrium structure or a kinetically
trapped structure. The latter possibility could arise from an
activation energy barrier to peptide incorporation into the
membrane. If this barrier could be overcome, a different
membrane-associated structure might be formed such as the
helical monomer observed in detergent at peptide/detergent
;0.01 (Chang et al., 1997a; Chang and Cheng, 1998). This
issue is investigated by comparing the spectra from NMR
samples prepared by two very different methods. In one
method, peptides bind directly to large unilamellar vesicles
(LUVs) in aqueous solution and induce lipid mixing and
fusion. For this approach, the initial interaction of peptide and
lipid is very similar to that of functional fusion assays. In the
second incorporation method, peptide, lipid, and cholesterol
are initially cosolubilized in organic solvent, the solvent is
then evaporated, and the mixture rehydrated to form
membranes. Because the components initially form a clear
homogeneous organic solution without lipid bilayers, there
may be a reduced barrier to peptide incorporation with the
lipid. For other helical peptides such as gramicidin and
magainin, it is also known that with peptide/lipid # 0.1,
organic dissolution followed by rehydration yields peptides
with helical structure (Ketchem et al., 1993; Ramamoorthy
et al., 1995; Hirsh et al., 1996; Opella et al., 1999).
MATERIALS AND METHODS
Materials
Rink amide resin was purchased fromAdvanced Chemtech (Louisville, KY),
and 9-ﬂuorenylmethoxycarbonyl (FMOC)-amino acids were obtained from
Peptides International (Louisville, KY). Labeled amino acids were purchased
from Icon Services (Summit, NJ) and were FMOC-protected using
literature methods (Chang et al., 1980; Lapatsanis et al., 1983).
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-
sn-glycero-3-(phospho-L-serine) (POPS), phosphatidylinositol (PI),
1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (POPG),
sphingomyelin, N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-phosphatidylethanol-
amine (N-NBD-PE), N-(lissamine Rhodamine B sulfonyl)-phosphatidyleth-
anolamine (N-Rh-PE), and cholesterol were purchased from Avanti Polar
Lipids (Alabaster, AL). The Micro bicinchoninic acid (BCA) protein assay
was obtained from Pierce (Rockford, IL). HEPES and Triton X-100 were
obtained from Sigma (St. Louis, MO). All other reagents were analytical
grade. The buffer solution used in the study contained 5mMHEPES (pH 7.0)
with 0.01% NaN3.
Peptides
Four different peptide constructs were synthesized. FP (AVGIGALFLGFL-
GAAGSTMGARS) corresponded to the 23N-terminal residues of the LAV1a
strain of HIV-1 gp41; FPK3 (AVGIGALFLGFLGAAGSTMGARSKKK)
contained three additional C-terminal lysines to increase peptide solubility in
aqueous solution; FPW (sequence AVGIGALFLGFLGAAGSTMGARSW)
contained an additional C-terminal tryptophan whose 280-nm absorbance
was useful for the analytical ultracentrifugation studies; and FPK3W
(AVGIGALFLGFLGAAGSTMGARSKKKW) contained both the C-termi-
nal lysines and tryptophan. All peptides were synthesized as their C-terminal
amides using a peptide synthesizer (ABI 431A, Foster City, CA) equipped for
FMOC chemistry. After synthesis, peptides were cleaved from the resin in a
3-h reaction using a mixture of TFA/H2O/phenol/thioanisole/ethanedithiol in
a 33:2:2:2:1 vol ratio. Peptides were subsequently puriﬁed by reversed-phase
high-performance liquid chromatography (HPLC) using a preparative C18
column (Vydac, Hesperia, CA) and a water/acetonitrile gradient containing
0.1% TFA. Mass spectroscopy was used for peptide identiﬁcation. For the
solid-state NMR experiments, peptides were synthesized with a 13C carbonyl
label at Phe-8 and a 15N label at Leu-9.
Analytical ultracentrifugation
Sedimentation equilibrium experiments at room temperature were per-
formed on Beckman XL-I and XL-A analytical ultracentrifuges (Palo Alto,
CA) using An-60 Ti rotors. The instruments were operated in absorbance
mode at either 225, 230, or 280 nm. Samples were loaded into six-channel
epon charcoal-ﬁlled centerpieces equipped with quartz windows and were
equilibrated at rotor speeds between 3000 and 52,000 rpm. Data were ﬁtted
with the analysis software supplied by Beckman.
Lipid preparation
A lipid and cholesterol mixture was used that reﬂected the approximate lipid
headgroup and cholesterol composition of membranes of host cells of the
HIV-1 virus (Aloia et al., 1993). This mixture (denoted ‘‘LM3’’) contained
POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine, 1-palmitoyl-
2-oleoyl-sn-glycero-3-(phospho-L-serine), sphingomyelin, phosphatidylinosi-
tol, and cholesterol in a 10:5:2:2:1:10 mol ratio. Preparation of large
unilamellar vesicles began with dissolution of lipid and cholesterol powders
in chloroform. The chloroform was removed under a stream of nitrogen
followed by overnight vacuum pumping. Lipid dispersions were formed by
addition of 5 mM pH 7 HEPES buffer followed by homogenization with 10
freeze-thawcycles. LUVsof 100-nmdiameterwere subsequently prepared by
extrusion (Hope et al., 1985).
Lipid mixing assay of membrane fusion
A resonance energy transfer assay was used to monitor membrane fusion
(Struck et al., 1981). Two types of 100-nm diameter LM3 LUVs were
prepared. One set contained 2 mol % of the ﬂuorescent lipid N-(7-nitro-2,1,
3-benzoxadiazol-4-yl)-phosphatidylethanolamine and 2 mol % of the
quenching lipid N-(lissamine Rhodamine B sulfonyl)-phosphatidylethanol-
amine, whereas the other set only contained unlabeled lipids. Fluorescently
labeled and unlabeled vesicles were mixed in a 1:9 ratio. After addition of the
fusion peptide, lipid mixing between labeled and unlabeled vesicles caused
dilution of the labeled lipids with a resulting increase of ﬂuorescence.
Fluorescence was recorded using 4 nm bandwidth on an Instruments S. A.
Fluoromax-2 spectroﬂuorimeter (Edison, NJ) operating at excitation and
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emission wavelengths of 465 and 530 nm, respectively. A siliconized glass
cuvette was used with continuous stirring in a thermostated cuvette holder.
Measurements were carried out at 37C with 2 ml LUVs (150 mM total lipid
and 75 mM cholesterol) in buffer solution. The initial residual ﬂuorescence
intensity, F0, referenced zero lipid mixing. After quantitation of the peptide
concentration with amino acid analysis, the requisite volume of 100 mM
peptide in 5 mM pH 7 HEPES was added manually to achieve the desired
peptide/lipid mol ratio. After addition and manual mixing of the peptide, the
ﬂuorescence (Ft) of the sample was monitored as a function of time and
eventually reached a constant value. The maximal ﬂuorescence intensity,
Fmax, was then obtained after addition of 10 ml 20% Triton X-100 detergent.
Ft and Fmax were corrected for the small ﬂuorophore dilution resulting from
the added volumes of peptide and Triton X-100. Percent lipid mixing at time t
is denoted asMt and was calculated using
Mt ¼ ½ðFt  F0Þ=ðFmax  F0Þ3 100: (1)
The long-time or ﬁnal extent of lipid mixing is denoted as Mf and was used
to compare the relative fusogenicities of different peptide constructs. For
a given set of labeled and unlabeled vesicles, Mf had 62% reproducibility
between different assay trials. Rates of lipid mixing are another measure of
fusogenicity but could not be accurately obtained from the experimental data
because the time taken for manual addition and mixing of the peptide was
signiﬁcant relative to characteristic fusion times. In future studies, these rates
could be determined using data obtained on a stopped-ﬂow ﬂuorimeter.
Preparation method 1 for membrane-associated
fusion peptide samples for solid-state
NMR studies
Peptide (;0.4 mmol) was dissolved in ;35 ml buffer. LUVs of LM3
(40mmol total lipid and 20mmol cholesterol) were prepared in;2ml buffer.
The vesicle and peptide solutions were mixed and sat overnight at room
temperature. The peptide/lipid mixture was then ultracentrifuged at 100,000
3 g for 4 h so that the membrane and associated peptide pelleted. FP and
FPK3 binding were typically quantitative as determined by bicinchoninic
acid assay measurements of negligible peptide concentration in the super-
natant. The pellet was transferred by spatula to a 6-mm diameter magic
angle spinning (MAS) NMR rotor.
Preparation method 2 for membrane-associated
fusion peptide samples for solid-state
NMR studies
Peptide, lipid, and cholesterol (0.4 mmol:40 mmol:20 mmol) were
codissolved in a solvent mixture made from triﬂuoroethanol, chloroform,
and hexaﬂuoropropanol in a 2:3:2 vol ratio. Solvent was removed by
gaseous nitrogen followed by overnight vacuum pumping. The mixture was
then hydrated in 2 ml buffer solution and subjected to six freeze-thaw cycles.
An additional 34 ml buffer solution was added and the sample was then
ultracentrifuged at 100,000 3 g for 4 h. The pellet was transferred to the
NMR rotor.
Solid-state NMR spectroscopy
In membrane-associated fusion peptide samples, room temperature 13C
cross-polarization NMR signals are attenuated, presumably because of slow
motion. Because there is three times higher 13C signal/noise at 50C
relative to room temperature, measurements in this study were made at the
lower temperature. In previous studies of these types of samples,
comparative 13C NMR spectra have been obtained at room temperature
and at 50C, and changes in individual shifts were less than 0.5 ppm over
this temperature range (Bodner et al., 2004). Because NMR chemical shifts
are diagnostic of peptide structure, it is likely that the peptide structure
observed at 50C is similar to the structure at more physiologically
relevant temperature. The temperature independence of the shifts was
observed both for helical and b-strand fusion peptide structures.
Experiments were done on a 9.4 T spectrometer (Varian Inﬁnity Plus,
Palo Alto, CA) using a triple resonance MAS probe. The NMR detection
channel was tuned to 13C at 100.8 MHz, the decoupling channel was tuned
to 1H at 400.8 MHz, and the third channel was tuned to 15N at 40.6 MHz.
Experiments were carried out using a MAS frequency of 8000 Hz that was
stabilized to62 Hz. For the NMR experiments, peptides were 13C carbonyl
labeled at Phe-8 and 15N amide labeled at Leu-9. NMR spectra were taken
using a REDOR ﬁlter of the 13C-15N dipolar interaction so that the Phe-8
carbonyl was the only signal observed in the 13C-detected REDOR
difference spectrum (Gullion and Schaefer, 1989; Yang et al., 2002). The
ﬁltering is important because it allows background-free observation of the
distribution of chemical shifts of the labeled Phe-8, which is the spectral
feature of interest. Without ﬁltering, this distribution is superimposed on the
13C natural abundance background due to peptide and lipid.
Between 1 and 2 ms of cross-polarization at 50 kHz was followed by a 1-ms
REDOR dephasing period and then direct 13C detection. A single 50-kHz
13C refocusing p-pulse was placed at the center of the dephasing time, and
1H TPPM decoupling of 65 kHz was applied during both dephasing and
detection (Bennett et al., 1995). 13C chemical shifts were referenced to the
methylene resonance of adamantane (38.5 ppm) and the 13C transmitter was
set to 155 ppm. 15N chemical shifts were referenced to (NH4)2SO4 (20 ppm)
and the 15N transmitter was set to 115 ppm. For the S1 acquisition, the
dephasing time contained a 40-kHz 15N p-pulse at the middle and end of
each rotor cycle, except for the ends of the fourth and eighth cycles, whereas
the S0 acquisition did not contain these pulses. XY-8 phase cycling was used
for the 15N pulses (Gullion et al., 1990; Gullion and Schaefer, 1991). During
the dephasing period, pulses were not actively synchronized to the rotor
phase. To obtain optimal compensation of B0, B1, and spinning frequency
drifts, S0 and S1 acquisitions were acquired alternately. The recycle delays
were between 1 and 2 s.
RESULTS
Analytical ultracentrifugation
Fig. 1 a displays one example of sedimentation equilibrium
data and ﬁtting for an 80-mM solution of FPK3W in 5 mM
pH 7 HEPES buffer. The rotor speed was 52,000 rpm, and
the peptide concentration was approximately the same as the
100-mM concentration of stock peptide solutions used in the
lipid mixing fusion assays. The bottom panel of Fig. 1 a
displays 280-nm absorbance (proportional to peptide concen-
tration) as a function of centrifugal radius. The data were ﬁt
to a single molar mass (M) using
ðA=A0Þ ¼ exp½Mð1 nrÞðr2  r20Þðv2=2RTÞ; (2)
where A and A0 are the experimental absorbances at radius r
and reference radius r0, respectively, n is the partial speciﬁc
volume of FPK3W, r is the buffer density, v is the angular
velocity, R is the ideal gas constant, and T is the temperature
(Cantor and Shimmel, 1980). This equation assumes no
baseline offset and a single value of M, i.e., a single self-
association state for all peptides in solution. The value of n
(0.76 ml/g) was calculated from the mass average of the
partial speciﬁc volumes of the individual amino acids in
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FPK3W (Laue et al., 1992). The value of rwas set to 1.0 g/ml.
The displayed data were best ﬁt toM¼ 2600 g/mol, which is
close to themonomer mass of 2690 g/mol. As displayed in the
top panel of Fig. 1 a, the differences between the experimental
and ﬁtted absorbances were small and random as a function of
r, which indicates that a single-species model is reasonable.
Additionally, a plot of ln(A) versus r2 was linear, as would be
expected from Eq. 1. Data were also acquired at 35,000 and
45,000 rpm and could be ﬁt well to Eq. 1 with values of M
between 2550 and 2700 g/mol. Thus, these studies demon-
strate that FPK3W at ;100-mM concentration is predomi-
nantly monomeric in 5 mM pH 7 HEPES buffer.
Fig. 1 b displays analytical ultracentrifugation data for
a solution containing 80-mM FPW in the buffer solution.
Peptide pelleting was observed at speeds above 15,000 rpm,
so the displayed data were obtained at 5000 rpm. A mean
value ofM; 230,000 g/mol was estimated from linear ﬁtting
and corresponds to ;100 peptide molecules. However, the
experimental data has substantial curvature, which indicates
that there is a signiﬁcant distribution of oligomer/aggregate
sizes.
Analytical ultracentrifugation experiments were also
attempted on FP and FPK3 with detection of peptide con-
centration at 225 or 230 nm. Quantitative analysis of the
data was difﬁcult because of subtraction of the large buffer
absorbance at this wavelength. At high speeds, some pelleting
was observed for FP (but not for FPK3), which indicated that
there was a population of larger FP oligomers or aggregates.
Some information about the association state of FP can also
be gleaned from the results of previous measurements of
amide 1HNMR linewidths for neutral aqueous solutions of FP
at 100-mM concentration (Yang et al., 2001a). The narrowest
linewidths were ;15 Hz, and through approximate hydro-
dynamic modeling these linewidths can be correlated to
a heptamer peptide mass (Cavanaugh et al., 1996). Solvent
exchange also contributes to the observed linewidths, so the
true mass may be smaller and might even correspond to the
monomer mass. In addition, comparison of solubilities and
rates of dissolution of the different peptide constructs yields
the ordering FPW , FP , FPK3W, FPK3.
In summary, the analytical ultracentrifugation data show
that in the 5-mM HEPES buffer solution 1), FPW is
predominantly associated as large oligomers/aggregates; 2),
there is a population of FP that forms large oligomers/
aggregates; and 3), FPK3W is predominantly monomeric.
Because FPK3 contains the same number of charged residues
as FPK3W and has comparable solubility properties to
FPK3W, we think that FPK3 is also predominantly
monomeric in the buffer solution. Because FP has solubility
properties that are intermediate between FPW and FPK3W,
and because of the observation of solution NMR signals for
FP in aqueous solution, we suggest that FP solutions also
contain a population of oligomers that are intermediate in size
between monomers and large aggregates. FP solutions may
also contain a population of monomer peptides.
Lipid mixing
Fig. 2 displays plots of Mt versus time for each of the
constructs with (a) peptide/lipid ¼ 0.01 and (b) peptide/lipid
¼ 0.02. All peptides induce signiﬁcant lipid mixing. At
peptide/lipid ¼ 0.01, the ordering of Mf values for the
different peptides is FPW , FPK3, FPK3W , FP, whereas
at peptide/lipid¼ 0.02, the ordering is FPW, FPK3W, FP,
FPK3. Overall, FPW appears to be the least fusogenic
whereas FP is the most fusogenic. The data in the analyti-
cal ultracentrifugation section suggest that the solution
FIGURE 1 (a) Sedimentation equilibrium data and analysis at 20C of
a sample made with 80 mM FPK3W peptide in 5 mM pH 7 HEPES buffer.
The bottom panel displays the 280-nm absorbance as a function of
centrifugal radius. The data are represented as open circles and were
obtained after 20 h spinning at 52,000 rpm. The superimposed curve
represents the best ﬁt to the data and was obtained using a molar mass of
2600 g, which is comparable to the 2700-g molar mass of a peptide
monomer. The upper panel shows the differences between the experimental
and best-ﬁt absorbances. (b) Sedimentation equilibrium data at 5000 rpm of
a sample made with 80 mM FPW peptide in 5 mM pH 7 HEPES buffer. The
logarithm of 280-nm absorbance is plotted as a function of (radius)2. The
data are represented as dark circles and show signiﬁcant curvature, which
indicates that the peptide does not form a single oligomeric species. The
dark-dotted and light-dashed lines represent the results that would be
expected for 230,000- and 2300-g molar mass species and correspond to
FPW 100 mers and monomers, respectively. It appears that the solution
contains large FPW oligomers.
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oligomerization states of the peptides are FPK3W and FPK3,
monomeric; FP, mixture of small and large oligomers; and
FPW, large oligomers/aggregates. Thus, there does not
appear to be a linear relationship between solution oligomer-
ization state and fusogenicity, although it may be that small
oligomers (FP) promote lipid mixing more efﬁciently than
monomers (FPK3W and FPK3) or large aggregates (FPW).
Solid-state NMR spectra
Fig. 3 displays 13C NMR spectra of HIV-1 fusion peptides.
Panels a and b, respectively, represent unﬁltered (S0) and
REDOR-ﬁltered (S0  S1) 13C NMR spectra of a membrane-
associated peptide sample prepared by method 1 and
containing FPK3 (;0.4 mmol) and LM3 (40 mmol total lipid
and 20 mmol cholesterol). The REDOR-ﬁltered spectrum is
dominated by the Phe-8 carbonyl signal with near-quantita-
tive suppression of natural abundance 13C signals. Panels c–j
display the carbonyl regions of REDOR-ﬁltered spectra. The
Phe-8 chemical shift distribution in each spectrum provides
information about the local Phe-8 conformation in the sample,
as will be described subsequently. Spectra c–d are for
lyophilized peptides, spectrum e is for peptide associated
with detergent, and spectra f–j are for peptides associated with
LM3 membranes.
It would be very interesting to have solid-state NMR
spectra of the peptides in frozen solutions at the ;100-mM
concentrations that were used in the analytical ultracentri-
fugation studies and that were used in the stock peptide
solutions of the fusion assays. These frozen solution spectra
could be compared with the solid-state NMR spectra of
detergent- and membrane-associated peptides and could
provide some information about conformational distributions
in solution. However, for our 400-MHz NMR spectrometer,
the detection limit is ;0.2 mmol 13C labeled peptide, and in
the 160-mL rotor volume a 100-mM peptide sample would
only contain ;0.02 mmol peptide. Although the frozen
solution experiments are unfeasible, we made some effort to
probe the solution state by obtaining spectra of lyophilized
aqueous solutions of FP or FPK3. The peptide concentrations
before lyophilization were ;500 and 100 mM, respectively,
and the lyophilized peptide NMR spectra are displayed in Fig.
3, c and d. Both spectra show distinct peaks at 174–175 and
171–172 ppm, which indicate that there are at least two Phe-8
conformations in the lyophilized state. Possible assignments
for these conformations will be given after the following
discussion of the spectra of the detergent- and membrane-
associated peptides.
To obtain information about the fusion peptide monomer
in a lipid-like environment, we made a sample containing
;0.3 mmol FPK3 and ;30 mmol dodecylphosphocholine
(DPC) in buffer. In this sample, each micelle contained
approximately one peptide and ;100 detergent molecules.
Fig. 3 e displays the NMR spectrum of this sample (obtained
at 80C) and contains a signal peaked at 175–176 ppm.
Panels f–j display spectra of different fusion peptide
constructs associated with LM3, and each contained
;0.4 mmol peptide, 40 mmol lipid, and 20 mmol cholesterol.
The samples in f–iwere made by method 1 and contained FP,
FPK3, FPW, and FPK3W, respectively, and the sample in
j was made by method 2 and contained FPK3. All of the
spectra in f–j have similar appearances with symmetric
lineshapes, peak chemical shifts of 171–172 ppm, and full-
width at half-maximum (FWHM) linewidths of ;2.5 ppm.
Previous studies have provided information about the local
secondary structure near Phe-8 in the HIV-1 fusion peptide in
different environments. We use these studies in conjunction
with known correlations between chemical shifts and
conformation to understand the spectra and local Phe-8
conformations in the NMR samples. For FP associated with
detergent at peptide/detergent; 0.01, a solution NMR study
showed predominant helical structure from Ile-4 to Gly-16
whereas, for FP associated with LM3, 2D solid-state NMR
measurements were consistent with predominant b-strand
structure from Val-2 to Ala-15 (Chang et al., 1997a; Yang
et al., 2001a; Gabrys et al., 2003). Considering these results, it
FIGURE 2 Lipid mixing induced in 100-nm diameter LM3 vesicles by
fusion peptides. The total lipid and cholesterol concentrations were 150 and
75 mM, respectively, and the same batches of vesicles were used for all
assays. In a and b, the curves correspond to the following peptides: (i) FP;
(ii) FPK3; (iii) FPK3W; and (iv) FPW. In a, the peptide concentration was
1.5 mM, and in b the peptide concentration was 3.0 mM. Data acquisition
began after manual addition and mixing of the peptide in the vesicle
solution. Because the time for these steps is signiﬁcant relative to
characteristic lipid mixing times, the apparent lipid mixing is nonzero at 0 s.
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is most reasonable to assign the 175–176-ppm Phe-8 signal in
Fig. 3 e to helical structure and the 171–172-ppm signal in f to
b-strand structure. These assignments are generally consis-
tent with the 175- and 169-ppm carbonyl shifts of solid
a-helical and solid b-sheet polyphenylalanine, respectively,
andwith the 175.1-6 1.4-ppm (helical) and 172.2-6 1.6-ppm
(b-strand) shift distributions observed for Phe carbonyls in
soluble proteins (Kricheldorf and Muller, 1983; Saito, 1986;
Zhang et al., 2003). These distributions are derived from
a chemical shift database of soluble proteins of known
structures, and each distribution contains .50 shifts. The
referencing for both the solid-state shifts and for the solution
shift distributions can be traced to neat tetramethylsilane at
0 ppm (Wishart et al., 1995; Morcombe and Zilm, 2003).
The previously described 175–176-ppm assignment to
helical Phe-8 and 171–172-ppm assignment to b-strand Phe-
8 are used to interpret the other spectra displayed in Fig. 3. In
particular, the similar shifts observed for FP, FPK3, FPW,
and FPK3W associated with LM3 membranes ( f–j) suggest
that Phe-8 has b-strand structure in all of these samples. In
addition, the b-strand structure is dominant for either
aqueous (g) or organic ( j) incorporation of FPK3 peptide
with lipid.
For LM3-associated FP and FPK3, interpeptide REDOR
measurements have shown that the peptide forms b-strand
oligomers, and we expect the Phe-8 b-strand structure
observed for LM3-associated FPW and FPK3W also
correlates with oligomer formation (Yang and Weliky,
2003). In the FPK3/detergent sample, there was about one
peptide per micelle, so it is likely that the peptide is
monomeric. For a monomeric peptide embedded in an apolar
environment, hydrogen bonding with water is improbable,
and helical structure will likely be favored because it
maximizes intrapeptide hydrogen bonding. In the membrane
samples, there are 102–103 peptides per unfused vesicle, and
there is the possibility of interpeptide hydrogen bonding and
formation of oligomeric b-strand structure either before or
after fusion has occurred. For detergent micelles, it has also
been shown that there is an increase in b-strand structure
with increased peptide/detergent ratio (Gordon et al., 1992).
At FP/detergent ¼ 0.005, the CD spectrum was deconvolved
as 55% a-helical and 45% random coil, whereas at FP/
detergent ¼ 0.1 (several peptides per micelle) the spectrum
FIGURE 3 13C solid-state NMR spectra of fusion peptide samples.
Spectrum a is the unﬁltered S0 spectrum of an FPK3/LM3 sample containing
;0.4 mmol peptide, 40 mmol total lipid, and 20 mmol cholesterol, and
spectrum b is the REDOR-ﬁltered difference spectrum of this sample.
Because the peptide was 13C carbonyl labeled at Phe-8 and 15N labeled at
Leu-9, the difference spectrum is dominated by the Phe-8 carbonyl signal.
The vertical scale in spectrum b is expanded by a factor of ;6.5 relative to
the scale in spectrum a. In c–j, REDOR-ﬁltered difference spectra are
displayed for samples containing different fusion peptide constructs: (c) FP
freeze-dried from a ;500-mM aqueous solution; (d ) FPK3 freeze-dried
from a ;100-mM aqueous solution; (e) FPK3 (2 mM) in dodecylphos-
phocholine detergent solution (200 mM); ( f ) FP, (g and j) FPK3, (h) FPW,
and (i) FPK3W associated with LM3 (;0.4 mmol peptide, 40 mmol total
lipid, and 20 mmol cholesterol). The samples used for spectra f–i were made
by method 1, with mixing of aqueous peptide and vesicle solutions. The
sample used for spectrum j was made by method 2, with organic
cosolubilization of peptide, lipid, and cholesterol, followed by evaporation
of the organic solvent and hydration with aqueous buffer. The spectra in c
and d display two peaks and indicate conformational heterogeneity for the
lyophilized peptide. The spectrum in e is peaked in the 175–176-ppm range,
and the spectra in f–j are peaked in the 171–172-ppm range. The chemical
shifts are consistent with helical structure near Phe-8 for the detergent
sample and b-strand structure near Phe-8 for the LM3 samples. Data were
acquired using cross-polarization, 8-kHz MAS frequency, and temperatures
of 50C for spectra a–d and f–j and 80C for spectrum e. Each spectrum
was processed with 50-Hz Gaussian line broadening and polynomial
baseline correction. There were 12,288 transients summed in spectrum a,
and the total (S0 1 S1) numbers of transients in the REDOR-ﬁltered
difference spectra were (b) 24,576; (c) 20,000; (d ) 31,488; (e) 132,524; ( f )
22,336; (g) 24,576; (h) 159,808; (i) 186,560; and ( j) 166,336.
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was deconvolved as 40% a-helical, 35% b-strand, and 25%
random coil. The increased b-strand content may be due to
formation of b-strand oligomers within the micelle.
The presence of two components in the lyophilized FP and
FPK3peptide spectra (panels c–d) is consistentwith amixture
of conformations. The component centered at 171–172 ppm
likely corresponds to b-strand structure, whereas the
component centered at 174–175 ppm likely corresponds to
helical or other non-b-strand structure. This latter component
is not observed in the spectra of any of the membrane-
associated peptides and suggests that there is a signiﬁcant
conformational change near Phe-8 for a large fraction of the
FP and FPK3 peptides when they bind to LM3 membranes.
There are at least two explanations for the origin of the 171–
172-ppm b-strand component in the lyophilized peptides. It
may be that the b-strand component is not found in aqueous
solution and results instead from b-strand formation during
lyophilization. An alternative explanation is that the b-strand
conformation exists in aqueous solution and is in rapid
interconversion with other conformations. The possibility of
rapid interconversion is supported by a fairly narrow (;1
ppm) distribution of amide 1H shifts for these peptides in
solution (Cavanaugh et al., 1996; Yang, 2003). The
interconversion would then be stopped by freezing and
lyophilization. In this model, each peptide in the lyophilized
state has a conformation close to the one that it had just before
freezing, and the distribution of conformations among all of
the lyophilized peptides is approximately the same as the
conformational distribution in solution. It is known that there
is a good correlation between the solution and lyophilized
conformational distribution for a 17-residue predominantly
a-helical peptide (Long and Tycko, 1998; Balbach et al.,
2000; Yang and Weliky, 2003).
As described in the previous paragraph, there are two
interpretations of the 171–172 ppm b-strand component of
the lyophilized peptides: 1), formation of b-sheet structure
during lyophilization; and 2), a b-strand conformation that
interconverts rapidlywith other conformations in solution and
that is trapped by lyophilization. If the ﬁrst interpretation is
correct, then the 174–175 component would likely corre-
spond to peptides that had not converted to b-strand during
lyophilization. It is likely that this latter population of peptides
was conformationally disordered in solution, as evidenced by
solution CD spectra that did not correlate well with model
spectra of either a-helical, b-strand, or random coil
conformations (Chang et al., 1997b; Yang, 2003). However,
analysis of the lyophilized FPK3 spectrum yielded a 3-ppm
linewidth (full-width at half-maximum) for the 174–175-ppm
component, which is narrower than the 5–6-ppm linewidths
of labeled carbonyl resonances in ;10 mM frozen solutions
of conformationally disordered antibody epitope peptides, as
well as the 5–6-ppm linewidths of solid peptides lyophilized
from these solutions (Weliky et al., 1999; Yang et al., 2001a;
D. P. Weliky, unpublished data). Given the 5–6-ppm
linewidth expected for disordered structure, it may be more
reasonable to assign the total 170–176-ppm signals in Fig. 3, c
and d, to the aqueous peptide conformation rather than just the
174–175-ppm component.
In summary, 1), comparison of spectra c and d and f–i in
Fig. 3 suggests that a signiﬁcant fraction of the peptides
convert from non-b-strand conformation in solution to
b-strand conformation after association with the membrane;
and 2), the b-strand structural component in the lyophilized
peptide may reﬂect some b-strand conformation in aqueous
solution or may be an artifact of lyophilization.
DISCUSSION
The importance of fusion peptide oligomers in viral/target cell
fusion has been implied by the large reduction in fusion
observed for viruses containing predominantly wild-type
fusion peptide and small amounts of mutant fusion peptide
(Freed et al., 1992). A similar relationship has been observed
in the fusion peptide model system, and formation of
a correctly assembled HIV-1 fusion peptide oligomer has
also been postulated as an important step in membrane fusion
catalysis (Kliger et al., 1997; Pritsker et al., 1999). Detection
of oligomers in the membrane-associated forms of FP, FPK3,
and other peptide constructs has been made by solid-state
NMR and other techniques, but it has not been clear whether
these oligomers preexisted in aqueous solution or whether
they formed upon membrane association. In this study, we
demonstrate that a peptide construct (FPK3W) that is
predominantly monomeric in aqueous solution adopts
b-strand structure upon membrane association. Previous
solid-state NMR studies have shown that the b-strand
structure is oligomeric, so it appears that oligomerization
can occur upon membrane association.
The b-strand structure was also observed for samples
prepared with initial cosolubilization of FPK3, lipid, and
cholesterol in organic solvent. Observation of the same
structure with both organic and aqueous incorporation of
peptide with lipid suggests that the b-strand is an equilibrium
rather than a kinetically trapped structure for peptide
associated with LM3 membranes. In particular, for the
organic approach, a homogeneous solution of lipid and
peptide was initially made without lipid bilayer structure,
which may make it easier to achieve ﬁnal equilibrium peptide
incorporation. In future work, equilibrium incorporation
could also be attempted by solubilization of peptide, lipid,
and cholesterol in surfactant solution, followed by removal of
the surfactant (Marassi et al., 1997).
Figs. 1 and 3 indicate that the membrane-associated
oligomeric b-strand structure can also result from peptide
that is initially oligomeric in aqueous solution. A remaining
question is whether differences in aqueous association state
correlate with more subtle structural differences in the
membrane-associated peptide, e.g., relative populations of
parallel and antiparallel strand arrangements and turn
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structures. Although this study does not address this issue, it
is noted that a previous solid-state NMR study provided
evidence for membrane-induced dissociation of putative
soluble FP oligomers (Yang and Weliky, 2003). Such
dissociation has also been inferred from CD and infrared
studies of the inﬂuenza fusion peptide (Han and Tamm,
2000b). Thus, the membrane-associated oligomeric structure
of the HIV-1 fusion peptidemay be somewhat independent of
the soluble peptide association state.
As discussed in the Introduction, the HIV-1 fusion pep-
tide as well as other fusion peptides can adopt a-helical
or b-strand conformation in membranes. At peptide/lipid
; 0.01, one of the strong determinants of the conformational
distribution is the lipid headgroup and cholesterol composi-
tion of the membrane. For LM3membranes, solid-state NMR
data for both the HIV-1 and inﬂuenza fusion peptide are
consistent with predominant b-strand structure, whereas in
membranes composed of POPC/POPG (4:1) lipids without
cholesterol, a-helical structure is predominant (Yang et al.,
2001a; Bodner et al., 2004; P. D. Parkanzky, M. Prorok,
F. J. Castellino, and D. P. Weliky, unpublished). The latter
observation is supported by infrared, circular dichroism, and
electron spin resonance data from the Tamm group (Han and
Tamm, 2000a; Han et al., 2001). In an effort to address the
question of the conformation of the fusion-active state, we
have carried out studies of lipid mixing induced by HIV-1 or
inﬂuenza fusion peptides between vesicles composed of LM3
or between vesicles composed of POPC/POPG. Comparable
lipid mixing is observed for both vesicle compositions, which
suggests that both the a-helical and the b-strand conforma-
tions are fusion active at least with respect to lipid mixing
(P. D. Parkanzky, M. Prorok, F. J. Castellino, and D. P.
Weliky, unpublished).
It is also possible that there is a transient fusogenic structure
that is unstructured or ﬂexible rather than a well-deﬁned
a-helical orb-strand conformation. TheUlrich group recently
argued in favor of this hypothesis based on comparison of
lipid mixing rates obtained for 18-residue internal fusion
peptides of the sea urchin bindin fertilization protein (Afonin
et al., 2003). In this study, similar rates were observed for
epimers containing either a L- or a D-4-ﬂuorophenylglycine
residue, and this result was contrary to the strong steric effect
on rate expected for a well-deﬁned structure. In our group, the
question of a transient structure has also been examined using
experiments that rely on the increased fusogenicity of the
inﬂuenza fusion peptide at pH 5.0 relative to pH 7.4 (P. D.
Parkanzky, M. Prorok, F. J. Castellino, and D. P. Weliky,
unpublished). The peptidewas bound to either LM3 or POPC/
POPGvesicles at pH7.4, and then in each sample lipidmixing
was monitored after lowering the pH to 5.0. For both the LM3
and POPC/POPG samples, there was a signiﬁcant increase in
lipidmixing after lowering the pH. Solid-state NMRchemical
shift measurements were consistent with a predominant
b-strand conformation in LM3 at pH 5.0 and pH 7.4 and with
predominant a-helical conformation in POPC/POPG at pH
5.0 and pH 7.4. Taken together, the lipid mixing and solid-
state NMR data argue in favor of lipid mixing induction by
both the a-helical and b-strand inﬂuenza fusion peptide
conformations and argue against a single transient fusogenic
conformation. Clearly, further experiments are required to
clarify the nature of the fusogenic structure.
In the next few paragraphs, we consider a possible model
that may explain the results of Fig. 2. As described in the
previous paragraphs, the structure(s) of the fusogenic form of
the peptide is not yet clearly understood, and our model is not
based on a particular structure. In Fig. 2, it is clear that lipid
mixing can be induced by both FPK3W and FPK3 (which are
predominantly monomeric) and by FP and FPW (which have
signiﬁcant populations of oligomers/aggregates). FP appears
to be the most fusogenic construct, and FPW is the least
fusogenic construct. Both FP and FPK3 bind quantitatively to
LM3 in the NMR sample preparation, so it is not likely that
the different fusogenicities are correlated with variations
in binding afﬁnities of the different constructs. It may be
possible to understand the fusogenicity data using aNc model
based on the hypothesis that lipid mixing requires membrane-
associated clusters whose number of peptides, N, exceeds
a critical number of peptides, Nc (Nieva et al., 1998). The
value of Nc could be based on the number of peptides needed
for a particular oligomeric structure (whichmight bea-helical
or b-strand ) and/or the free energy released whenNc peptides
bind to the membrane in close proximity (Han and Tamm,
2000a). In the simplest model, membrane disruption may be
correlated with the size of the cluster, and fusion may require
a degree of disruption that is only achieved forN$Nc clusters.
As the structures of the a-helical and b-strand forms of fusion
peptides become better elucidated, it may become possible to
test for an underlying structural basis of the Nc model.
Within this Nc model, the membrane-associated cluster
sizes for peptide/lipid¼ 0.01 are postulated:NFP;Nc;NFPK3,
NFPK3W , Nc; and NFPW  Nc. These sizes qualitatively
correlate with the putative soluble peptide oligomerization
states. In themodel, FPwould then have the largest number of
fusogenic clusters and the highest fusogenicity (Mf). This
prediction is consistent with the experimental fusogenicities
at peptide/lipid ¼ 0.01.
Other aspects of the experimental data displayed in Fig. 2
can be explainedwith thismodel. For example, comparison of
data at peptide/lipid ¼ 0.01 and 0.02 shows that the fuso-
genicities of FP and FPW are approximately proportional to
peptide/lipid. This might be expectedwhen the clusterN$Nc
at both peptide/lipid ratios and the number of fusogenic
clusters simply increases with peptide/lipid. By contrast, the
fusogenicities of FPK3 and FPK3W have nonlinear (greater
than proportional) dependences on peptide/lipid. This can be
understood in terms of a change in average cluster size fromN
,Nc at peptide/lipid¼ 0.01 toN;Nc at peptide/lipid¼ 0.02.
Our model is also supported by a previous lipid mixing
study done on cross-linked peptides and their noncross-
linked analogs (Yang et al., 2003). At peptide strand/lipid
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# 0.01, the cross-linked peptides had greater Mf than their
noncross-linked analogs, but at higher peptide strand/lipid
the Mf of all constructs were much more comparable. These
observations can be understood by the increase in local
peptide concentration due to cross-linking and the resulting
larger number of clusters with N . Nc. In accord with
experiment, the fusogenic enhancement of cross-linking
should be more important at lower strand/lipid (where
relatively few of the clusters have N . Nc) than at higher
strand/lipid (where most of the clusters have N. Nc). The Nc
model is also supported by lipid mixing studies of FP that
had been incubated for different lengths of time in 100 mM
NaCl solution (Pereira et al., 1997). In these studies, there
was an inverse relationship between Mf and incubation time
that can be understood in terms of an increase of N beyond
Nc as a function of incubation time. This latter prediction
correlates with experimental observations that higher ionic
strength leads to increased peptide aggregation in solution
(Han and Tamm, 2000b; Yang et al., 2001a).
In this study, incorporation of C-terminal lysines and
tryptophan was critical for synthesis and for analytical
ultracentrifugation veriﬁcation of a monomeric peptide state.
The overall synthetic and analytical ultracentrifugation
approach may also be generally useful for clariﬁcation of
oligomerization questions concerning different fusion peptide
constructs such as those that include large fusion protein
domains. For example, it has been common in structural and
functional studies of HIV-1 fusion peptides to ﬁrst dissolve
peptide in dimethylsulfoxide (DMSO) and then add an aliquot
of the dimethylsulfoxide solution to a liposome solution
(Martin et al., 1996; Pereira et al., 1997; Sackett and Shai,
2002; Haque and Lentz, 2002). Because the peptide con-
centration is much higher than the liposome concentration,
the rate of peptide/peptide collisions is much greater than
the rate of peptide/liposome collisions, and the oligomeric
state of the peptide is not known before binding to the
membrane (Steinfeld et al., 1999). Using the approach of this
article, it may be possible to ﬁnd conditions for which peptide
constructs that vary in length and/or sequence have well-
deﬁned oligomeric states in the buffer solution. This may
clarify the contribution of oligomerization to structure/
function relationships in these peptides.
CONCLUSIONS
Structural and functional comparisons were made between
four different HIV-1 fusion peptide constructs, two of which
were predominantly monomeric in aqueous solution and two
of which had signiﬁcant populations of oligomers/aggregates
in aqueous solution. When associated with membranes
comparable to those of host cells of the virus, all constructs
formed b-strand structure at Phe-8, and experiments suggest
that this is an equilibrium rather than a kinetically trapped
structure. The membrane-associated b-strand structure is
oligomeric, and this oligomerization can result from associ-
ation of soluble peptide monomers with membranes. There is
not a linear correlation between the solution oligomerization
state and the fusogenicity of the peptide construct, but the
functional data suggest that small peptide oligomers may be
more fusogenic than either peptidemonomers or large peptide
aggregates.
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